These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27542308)

  • 1. Recent progress on nuclear receptor RORγ modulators.
    Cyr P; Bronner SM; Crawford JJ
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4387-4393. PubMed ID: 27542308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
    Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
    ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo.
    Banerjee D; Zhao L; Wu L; Palanichamy A; Ergun A; Peng L; Quigley C; Hamann S; Dunstan R; Cullen P; Allaire N; Guertin K; Wang T; Chao J; Loh C; Fontenot JD
    Immunology; 2016 Apr; 147(4):399-413. PubMed ID: 26694902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).
    Fauber BP; Magnuson S
    J Med Chem; 2014 Jul; 57(14):5871-92. PubMed ID: 24502334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds.
    Zhang W; Zhang J; Fang L; Zhou L; Wang S; Xiang Z; Li Y; Wisely B; Zhang G; An G; Wang Y; Leung S; Zhong Z
    Mol Pharmacol; 2012 Oct; 82(4):583-90. PubMed ID: 22700697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
    Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
    J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RORγ antagonists and inverse agonists: a patent review.
    Bronner SM; Zbieg JR; Crawford JJ
    Expert Opin Ther Pat; 2017 Jan; 27(1):101-112. PubMed ID: 27629281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors.
    Karaś K; Sałkowska A; Walczak-Drzewiecka A; Ryba K; Dastych J; Bachorz RA; Ratajewski M
    Toxicol Lett; 2018 Oct; 295():314-324. PubMed ID: 29981919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.
    Ouvry G; Atrux-Tallau N; Bihl F; Bondu A; Bouix-Peter C; Carlavan I; Christin O; Cuadrado MJ; Defoin-Platel C; Deret S; Duvert D; Feret C; Forissier M; Fournier JF; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Huguet H; Lafitte G; Luzy AP; Musicki B; Orfila D; Ozello B; Pascau C; Pascau J; Parnet V; Peluchon G; Pierre R; Piwnica D; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
    ChemMedChem; 2018 Feb; 13(4):321-337. PubMed ID: 29327456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
    Kojima H; Takeda Y; Muromoto R; Takahashi M; Hirao T; Takeuchi S; Jetten AM; Matsuda T
    Toxicology; 2015 Mar; 329():32-9. PubMed ID: 25583575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.
    Hu X; Wang Y; Hao LY; Liu X; Lesch CA; Sanchez BM; Wendling JM; Morgan RW; Aicher TD; Carter LL; Toogood PL; Glick GD
    Nat Chem Biol; 2015 Feb; 11(2):141-7. PubMed ID: 25558972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
    Fauber BP; Gobbi A; Savy P; Burton B; Deng Y; Everett C; La H; Johnson AR; Lockey P; Norman M; Wong H
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4109-13. PubMed ID: 26321361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
    Fauber BP; Gobbi A; Robarge K; Zhou A; Barnard A; Cao J; Deng Y; Eidenschenk C; Everett C; Ganguli A; Hawkins J; Johnson AR; La H; Norman M; Salmon G; Summerhill S; Ouyang W; Tang W; Wong H
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2907-12. PubMed ID: 26048793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of biaryl carboxylamides as potent RORγ inverse agonists.
    Chao J; Enyedy I; Van Vloten K; Marcotte D; Guertin K; Hutchings R; Powell N; Jones H; Bohnert T; Peng CC; Silvian L; Hong VS; Little K; Banerjee D; Peng L; Taveras A; Viney JL; Fontenot J
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2991-7. PubMed ID: 26048806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
    Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
    Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists.
    Ouvry G; Bouix-Peter C; Ciesielski F; Chantalat L; Christin O; Comino C; Duvert D; Feret C; Harris CS; Lamy L; Luzy AP; Musicki B; Orfila D; Pascau J; Parnet V; Perrin A; Pierre R; Polge G; Raffin C; Rival Y; Taquet N; Thoreau E; Hennequin LF
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5802-5808. PubMed ID: 27815118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
    Jetten AM; Cook DN
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():371-390. PubMed ID: 31386594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tertiary sulfonamides as RORc inverse agonists.
    Fauber BP; René O; Burton B; Everett C; Gobbi A; Hawkins J; Johnson AR; Liimatta M; Lockey P; Norman M; Wong H
    Bioorg Med Chem Lett; 2014 May; 24(9):2182-7. PubMed ID: 24685544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity.
    Huang Z; Xie H; Wang R; Sun Z
    Expert Opin Ther Targets; 2007 Jun; 11(6):737-43. PubMed ID: 17504012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.